Notice2024-09047
Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 29, 2024
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 83 (Monday, April 29, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Pages 33373-33374]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-09047]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory
Board (DTAB) will convene in open session in person and via web
conference on June 4th, 2024, from 10:00 a.m. EST to 5:00 p.m. EST and
in closed session on June 5th, 2024 from 9:00 a.m. EST to 12:00 p.m.
EST.
The board will meet in open-session June 4, 2024, from 10:00 a.m.
EST to 5:00 p.m. EST to discuss the Mandatory Guidelines for Federal
Workplace Drug Testing Programs, hear updates from the Nuclear
Regulatory Commission, and discuss the availability of FDA 510(k)
cleared assays and urine verses oral fluid prevalence data and specimen
[[Page 33374]]
validity and biomarker testing. Presentations include one by Faye
Caldwell on industry moving parts pertaining to Oral Fluid
implementation and another by Dr. Edward Cone regarding Johns Hopkins
University study updates.
The board will meet in closed session on June 5, 2024, from 9:00
a.m. EST to 12:00 p.m. EST to discuss specimen validity testing data,
challenges to Oral Fluid testing and the status of the Hair Mandatory
Guidelines. All of these topics require input and discussion from Board
Members as to the next steps of Federal Workplace Drug Testing. The
DTAB meeting on June 5, 2024, from 9:00 a.m. EST to 12:00 p.m. EST, is
closed to the public, as determined by the Assistant Secretary for
Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C.
552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d).
Meeting registration information can be completed at <a href="https://snacregister.samhsa.gov/">https://snacregister.samhsa.gov/</a>. Web conference and call information will be
sent after completing registration. Meeting information and a roster of
DTAB members may be obtained by accessing the SAMHSA Advisory
Committees website, <a href="https://www.samhsa.gov/about-us/advisory-councils/meetings">https://www.samhsa.gov/about-us/advisory-councils/meetings</a>, or by contacting the Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse and Mental Health Services
Administration Center for Substance Abuse Prevention Drug Testing
Advisory Board.
Dates/Time/Type: June 4, 2024, from 10:00 a.m. EST to 5:00 p.m.
EST: OPEN; June 5, 2024, from 9:00 a.m. EST to 12:00 p.m. EST: CLOSED.
Place: Substance Abuse and Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD 20857.
To Submit Comments: Please send comments in writing at least 7 days
prior to the meeting to the to the following email:
<a href="/cdn-cgi/l/email-protection#ade9ebfafdeddeccc0c5decc83c5c5de83cac2db"><span class="__cf_email__" data-cfemail="0f4b49585f4f7c6e62677c6e2167677c21686079">[email protected]</span></a>.
Contact: Lisa S. Davis, M.S, Social Science Analyst, Center for
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland
20857, Telephone: (240) 276-1440, Email: <a href="/cdn-cgi/l/email-protection#7a3613091b543e1b0c13093a091b1712091b54121209541d150c"><span class="__cf_email__" data-cfemail="90dcf9e3f1bed4f1e6f9e3d0e3f1fdf8e3f1bef8f8e3bef7ffe6">[email protected]</span></a>.
Anastasia Flanagan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2024-09047 Filed 4-26-24; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 29, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.